| |
| |
|
| Insider
Information: |
Burrill Steven |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
92,384 |
|
|
Indirect Shares
|
32,196 |
|
|
| Direct
Value |
$42,200 |
|
|
|
Indirect Value
|
$2,215 |
|
|
| Total
Shares |
124,580 |
|
|
| Total
Value |
$44,415 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director |
2005-12-23 |
2,467 |
2005-12-23 |
27,863 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Director |
2011-05-12 |
0 |
2012-07-31 |
4,333 |
Premium* |
|
|
Assertio Holdings Inc |
ASRT |
Director |
2011-05-13 |
40,000 |
2008-11-26 |
0 |
Premium* |
|
|
Diadexus Inc |
DDXS |
10% Owner |
2013-10-30 |
49,917 |
2011-01-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2013-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,148,041 |
49,917 |
0 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2013-10-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,038,854) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2012-07-31 |
4 |
OE |
$0.08 |
$325 |
I/I |
4,333 |
4,333 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2011-05-13 |
4 |
OE |
$1.49 |
$225,950 |
D/D |
69,250 |
109,250 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2011-05-13 |
4 |
S |
$8.09 |
$560,025 |
D/D |
(69,250) |
40,000 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-12 |
4/A |
OE |
$2.71 |
$241,972 |
D/D |
33,052 |
33,052 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-12 |
4/A |
S |
$23.88 |
$789,345 |
D/D |
(33,052) |
0 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2011-05-12 |
4 |
S |
$8.25 |
$717,750 |
D/D |
(87,000) |
40,000 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2011-05-12 |
4 |
OE |
$1.95 |
$313,250 |
D/D |
62,000 |
127,000 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-11 |
4 |
OE |
$2.71 |
$241,972 |
D/D |
33,052 |
33,052 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-11 |
4 |
S |
$23.88 |
$789,345 |
D/D |
(33,052) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-10 |
4 |
S |
$24.13 |
$48,253 |
I/I |
(2,000) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-10 |
4 |
S |
$24.04 |
$407,471 |
D/D |
(16,948) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-10 |
4 |
OE |
$9.37 |
$158,803 |
D/D |
16,948 |
16,948 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2011-04-04 |
4 |
OE |
$3.40 |
$34,000 |
D/D |
10,000 |
65,000 |
0 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2011-02-07 |
4 |
B |
$0.40 |
$2,000 |
D/D |
5,000 |
5,518,974 |
2.37 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2011-02-03 |
4 |
B |
$0.40 |
$6,115 |
D/D |
15,287 |
5,513,974 |
2.37 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2011-02-02 |
4 |
B |
$0.40 |
$6,000 |
D/D |
15,000 |
5,498,687 |
2.37 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2011-02-01 |
4 |
B |
$0.39 |
$5,967 |
D/D |
15,300 |
5,483,687 |
2.37 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2011-01-28 |
4 |
B |
$0.38 |
$4,940 |
D/D |
13,000 |
5,468,387 |
2.37 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2011-01-24 |
4 |
B |
$0.40 |
$40,000 |
D/D |
100,000 |
5,455,387 |
2.37 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2011-01-21 |
4 |
B |
$0.40 |
$22,200 |
D/D |
55,500 |
5,355,387 |
2.37 |
- |
|
| DDXS |
Diadexus Inc |
10% Owner |
– – • |
2011-01-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,355,387 |
|
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2009-07-10 |
4 |
OE |
$2.88 |
$43,125 |
D/D |
15,000 |
55,000 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2008-11-26 |
4 |
B |
$1.45 |
$61,444 |
D/D |
40,000 |
40,000 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
